ProBio Email Format
Biotechnology ResearchNew Jersey, United States201-500 Employees
ProBio is a global contract development and manufacturing organization focused on advancing the production of advanced therapies. It provides development and manufacturing capabilities for DNA, RNA, and protein-based therapeutics, as well as biologics, vaccines, viral vectors, and antibody-drug conjugates, alongside drug discovery services. As a global partner, it brings together multidisciplinary expertise to support the development and manufacture of next-generation therapies. Based in New Jersey, ProBio maintains a state-of-the-art facility in Hopewell that serves as its North American hub for plasmid DNA and viral vector production. The company collaborates with biotechnology and pharmaceutical developers, offering development and manufacturing services designed to move discoveries toward market. In August 2025, ProBio announced the launch of GMP manufacturing for Adeno-Associated Virus at its Hopewell site, expanding its manufacturing capabilities.